GoodRx names new Chief Accounting Officer
GoodRx Holdings, Inc. appointed Thomas Chan as Chief Accounting Officer and designated him as the company’s principal accounting officer, effective immediately.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GoodRx Holdings, Inc. appointed Thomas Chan as Chief Accounting Officer and designated him as the company’s principal accounting officer, effective immediately. Chan has held increasing accounting and reporting roles at GoodRx since 2020 and previously worked in audit and assurance at Deloitte & Touche.
In connection with his promotion, Chan’s annual base salary was set at $310,000 with a target annual bonus of 40% of base salary. He will receive a restricted stock unit award valued at $131,250 and a performance-based restricted stock unit award valued at $43,750 under the 2020 Incentive Award Plan, with multi-year time- and performance-based vesting schedules tied to continued employment.
8-K Event Classification
Key Figures
Key Terms
Chief Accounting Officer financial
principal accounting officer financial
restricted stock unit award financial
performance-based restricted stock unit award financial
2020 Incentive Award Plan financial
indemnification agreement regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What leadership change did GoodRx (GDRX) disclose in this 8-K filing?
What is Thomas Chan’s new compensation as Chief Accounting Officer of GoodRx (GDRX)?
What equity awards will Thomas Chan receive from GoodRx (GDRX)?
How do Thomas Chan’s RSUs at GoodRx (GDRX) vest over time?
What is the vesting schedule for Thomas Chan’s performance-based RSUs at GoodRx (GDRX)?
AI-generated analysis. How Rhea-AI works. Not financial advice.